Tag: Ocugen

A prominent speaking opportunity for a biotech CEO typically generates positive market momentum. However, Dr. Shankar Musunuri's participation on a ...

A remarkable 20% single-day surge in Ocugen's share price has returned the biotechnology firm to investor focus. The company, which ...

Conflicting corporate developments have placed Ocugen shares on a volatile path, torn between a significant strategic setback and a promising ...

While Ocugen's market performance has faced challenges, professional analysts are sending a decidedly different message. On Friday, Chardan Capital reaffirmed ...

Biotechnology firm Ocugen finds itself at a critical juncture, simultaneously managing a significant corporate setback and a promising new international ...

A landmark licensing agreement has provided biotechnology firm Ocugen with a substantial confidence boost from investors. The company announced an ...

Biotechnology firm Ocugen has announced a fundamental restructuring of its operations, marking a decisive shift in corporate strategy. The company ...

Biotechnology firm Ocugen approaches a pivotal moment that could define its trajectory for the coming year. The company's presentation at ...

Ocugen has achieved a critical regulatory milestone after European Medicines Agency (EMA) officials endorsed the company's development strategy for its ...

In a notable strategic departure, biopharmaceutical firm Ocugen has announced a $5 million equity investment in fellow biotechnology company Carisma ...